Member access

4-Traders Homepage  >  Shares  >  Tokyo  >  Astellas Pharma Inc    4503   JP3942400007

SummaryChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll newsSector news 
Latest news on ASTELLAS PHARMA INC
03/01 ASTELLAS PHARMA : Announces Status of Acquisition of Own Shares (pdf 63KB)
02/27 CYTOKINETICS : Joins Global Movement to Raise Awareness for Rare Diseases
02/26 ASTELLAS PHARMA : Medivation Reports Fourth Quarter and Full Year 2014 Financial..
02/26 ASTELLAS PHARMA : Cytokinetics Announces Publication of Preclinical Data Relatin..
02/26 ASTELLAS PHARMA : and BDO Partner
02/25 ASTELLAS PHARMA : and BDO Partner
02/23 ASTELLAS PHARMA : and BlackDoctor.org (BDO) Team Up to Offer Health Education at..
02/19 ASTELLAS PHARMA : Recent Findings from Astellas Pharma, Inc. Provides New Insigh..
02/19 ASTELLAS PHARMA : Studies from Astellas Pharma, Inc. Yield New Data on Pharmacok..
02/16 ASTELLAS PHARMA : Launches the Newest Element in its Global Corporate Brand Camp..
02/13 ASTELLAS PHARMA : Launches the Newest Element in its Global Corporate Brand Camp..
02/11 ASTELLAS PHARMA : Findings from Astellas Pharma, Inc. Broaden Understanding of C..
02/11 ASTELLAS PHARMA : New Pharmacokinetics Study Findings Have Been Reported by Rese..
02/11 ASTELLAS PHARMA : Broadens Commitment to Clinical Trial Data Transparency
02/09 ASTELLAS PHARMA : Enhancement of Astellas' Management Structure
02/05 ASTELLAS PHARMA : Enhancement of Astellas' Management Structure (pdf 82KB)
02/05 ASTELLAS PHARMA : Announces Personnel Changes and Organization Changes (pdf 98KB..
02/04 ASTELLAS PHARMA : and Immunomic Therapeutics Announce Exclusive License for JRC2..
02/04 ASTELLAS PHARMA : Researchers at Astellas Pharma, Inc. Target Medicinal Chemistr..
02/04 ASTELLAS PHARMA : Reports from Astellas Pharma, Inc. Provide New Insights into H..
02/03 ASTELLAS PHARMA : Broadens Commitment to Clinical Trial Data Transparency
02/03 ASTELLAS PHARMA : Announces Acquisition of Own Shares(Under the provision of its..
02/02 ASTELLAS PHARMA : and Immunomic Therapeutics Announce Exclusive License for JRC2..
02/01 ASTELLAS PHARMA : Graduate School of Medicine/Faculty of Medicine, Osaka Univers..
02/01 ASTELLAS PHARMA : Announces Acquisition of Own Shares (pdf 62 KB)
02/01 ASTELLAS PHARMA : Broadens commitment to clinical trial data transparency
01/30 ASTELLAS PHARMA : to develop Immunomic's JRC2-LAMP-vax to treat Japanese red ced..
01/29DJValeant to Buy Prostate-Cancer Drug From Dendreon
01/29DJValeant in Deal to Buy Prostate-Cancer Drug Provenge From Dendreon
01/29 ASTELLAS PHARMA : and Immunomic Therapeutics Announce Exclusive License for JRC2..
01/29 ASTELLAS PHARMA : Study Data from Astellas Pharma, Inc. Update Knowledge of Proi..
01/29 MEDIVATION : and Astellas Pharma Reports Results from Phase 2 Terrain Trial
01/28 ASTELLAS PHARMA : New Chemometrics Findings from Astellas Pharma, Inc. Described..
01/28 MEDIVATION : and Astellas Pharma Releases Results from Phase 2 Terrain Trial
01/23 MEDIVATION : Astellas -enzalutamide phase 2 terrain trial demonstrated statistic..
01/22 ASTELLAS PHARMA : Announces FDA Anti-Infective Drugs Advisory Committee Recommen..
01/14 ASTELLAS PHARMA : Partners With Society of Cardiovascular Patient Care To "Bring..
01/14 ASTELLAS PHARMA : Reports from Astellas Pharma, Inc. Describe Recent Advances in..
01/08 ASTELLAS PHARMA : Reports from Astellas Pharma, Inc. Highlight Recent Findings i..
01/01 ASTELLAS PHARMA : New Findings from Astellas Pharma, Inc. in the Area of Clinica..
01/01 ASTELLAS PHARMA : Studies from Astellas Pharma, Inc. Provide New Data on Type 2 ..
2014 CYTOKINETICS : And astellas announce expansion of collaboration for development ..
2014 ASTELLAS PHARMA : New Findings from Astellas Pharma, Inc. in the Area of Clinica..
2014 ASTELLAS PHARMA : Studies from Astellas Pharma, Inc. Provide New Data on Type 2 ..
2014 ASTELLAS PHARMA : Cytokinetics and Astellas Announce Expansion of Collaboration ..
2014 MEDIVATION : Data presented from phase 2 study of enzalutamide in advanced andro..
2014 ENUMERAL BIOMEDICAL : Appoints Robert L. Van Nostrand to its Board of Directors
2014 ASTELLAS PHARMA : Findings from Astellas Pharma, Inc. Provide New Insights into ..
2014 ASTELLAS PHARMA : Findings from Astellas Pharma, Inc. Has Provided New Data on H..
2014 ASTELLAS PHARMA : Data to be presented from phase 2 study of enzalutamide in adv..
2014 ASTELLAS PHARMA : Named to FTSE4Good Sustainability Index for the Third Year
2014 ASTELLAS PHARMA : to end license agreement with Janssen for ASP015K inhibitor
2014 ASTELLAS PHARMA : New Findings from Astellas Pharma, Inc. in Tinea pedis Provide..
2014 ASTELLAS PHARMA : Researchers at Astellas Pharma, Inc. Release New Data on Hemep..
2014DJAbilify Maker Otsuka to Buy Avanir for $3.5 Billion
2014DJAbilify Maker Otsuka to Buy Avanir for $3.5 Billion
2014 ASTELLAS PHARMA : -enzalutamide (xtandi) now approved in europe for the treatmen..
2014 ASTELLAS PHARMA : Announces Personnel Change
2014 ASTELLAS PHARMA : Enzalutamide (xtandi) now approved in europe for the treatment..
2014 ASTELLAS PHARMA : Announces End of License Agreement with Janssen to Develop and..
2014 AMGEN : Astellas announces termination of Amgen-sponsored clinical studies of ri..
2014 ASTELLAS PHARMA : announces termination of Amgen-sponsored clinical studies of r..
2014 ASTELLAS PHARMA : Basilea reports that U.S. FDA sets date of Advisory Committee ..
2014 ASTELLAS PHARMA : opens new regional affiliate office for Middle East, North and..
2014 ASTELLAS PHARMA : Opens New Regional Affiliate Office for Middle East, North and..
2014 ASTELLAS PHARMA : The results of Japanese Clinical Trials of Anti-TNF-alpha Anti..
2014 ASTELLAS PHARMA : Dana-Farber Cancer Institute And Astellas Announce Research Co..
2014 NPS Pharma Names Pierre Legault to Board of Directors
2014 NPS Pharma Appoints Pierre Legault to Board Directors
2014 NPS Pharma Appoints Pierre Legault to Board of Directors
2014 ASTELLAS PHARMA : DANA-FARBER CANCER INSTITUTE AND ASTELLAS ANNOUNCE; Focus on r..
2014 ASTELLAS PHARMA : Changing Tomorrow Day 2014 Marks Astellas' Fifth Annual Global..
2014 ASTELLAS PHARMA : Proteostasis Therapeutics and Astellas Announce Collaboration ..
2014 ASTELLAS PHARMA : DANA-FARBER CANCER INSTITUTE AND ASTELLAS ANNOUNCE - Focus on ..
2014 ASTELLAS PHARMA : Changing Tomorrow Day 2014 Marks Astellas' Fifth Annual Global..
1  2  3  4  5Next
Advertisement
Chart
Duration : Period :
Astellas Pharma Inc Technical Analysis Chart | 4503 | JP3942400007 | 4-Traders
Income Statement Evolution
More Financials
Dynamic quotes  
ON
| OFF